This is not a clean GARP story — it’s a stressed balance sheet story masquerading as a cyclical recovery. A Forward P/E of 41.1 paired with an EPS estimate next year of -$0.41 signals an earnings cliff, not growth. The Altman Z-Score of 1.3 places the company in financial distress territory, and the Piotroski F-Score of 2 confirms weak underlying fundamentals. At a $1,419M market cap and 1.3x sales, the stock is not priced for bankruptcy — yet the quality metrics suggest elevated risk with deteriorating profitability. This is a speculative restructuring play, not a classic undervalued compounder.